Furthermore, knowledge about TP53 mutation may aid clinician to the best treatment modalities for these patient such as bilateral mastectomy to reduce the risk of a second primary breast cancer and minimizing the radiotherapy if possible since radiation therapy may increase risks in these patients [40, 41]. This evidence concerns the gene TP53 and breast carcinoma.